PALM HARBOR, Fla. – Nov. 2, 2004 – Vijay Singh was named this week's Crestor (rosuvastatin calcium) Charity Challenge winner for his first-place standing entering the final round of the Chrysler Championship.

The Crestor Charity Challenge is a season-long weekly competition that recognizes the tournament leader entering the final round at most PGA Tour events throughout the year. Through this first-of-its kind program, AstraZeneca and its Crestor product will donate approximately $3 million a year to health care and PGA Tour charities. At each of the selected tournaments, a $100,000 contribution will be made.

For Singh's performance, AstraZeneca, on behalf of its Crestor product and the Chrysler Championship, will donate $50,000 to Academy Prep Foundation's health and nutrition program, and $50,000 to the health care charity of Singh's choice.

"As all of our students are on full scholarships, Academy Prep's success clearly depends upon the volunteer and financial support of the community," said Ben Fisher, Executive Director of Academy Prep Foundation. "For this reason, we are truly grateful to AstraZeneca and Crestor for their commitment to the inner city children of Tampa Bay and their show of confidence in our programs. Academy Prep is about the long-term health of our students and our community, and their contribution will go a long way toward helping us accomplish our mission."

Academy Prep Centers are privately funded schools for inner city children who qualify for need-based scholarships. All students attend Academy Prep on full scholarships provided by the local community-from individuals, businesses and foundations. Academy Prep Center of St. Petersburg opened in 1997 and is the original Academy Prep Center in the Tampa Bay area. It currently serves boys and girls in grades 5-8 and supports graduates in grades 9-12 in local private and public schools and boarding schools around the country, as well as students in their first year of college. Academy Prep Center of Tampa opened in 2003 in historic Ybor City.

The Crestor Charity Challenge is the centerpiece of a multi-year PGA Tour partnership with AstraZeneca (NYSE: AZN) on behalf of its cholesterol-lowering medication, Crestor. "Giving back is at the heart of the PGA Tour and AstraZeneca is pleased to be able to support this by offering health education and recognizing local communities through the Crestor Charity Challenge," said Tony Zook, senior vice president, commercial operations, AstraZeneca U.S. "The Crestor Charity Challenge will not only add an exciting new twist to the PGA Tour, it will also help the Tour reach its milestone of $1 billion in charitable donations within the next few years."

Crestor Charity Challenge winners will be recognized during the network or cable telecast of each tournament. In addition, AstraZeneca and Crestor will sponsor the PGA Tour year-end charity special, which is scheduled to air December 18 on ABC.
The PGA Tour partnership also includes the Crestor Charity Challenge Pavilion, an on-site component at select tournaments featuring interactive exhibits designed to provide health and cholesterol awareness, educational activities, health screenings/assessments, and golf tips by teaching pros for fans.

Fans can log on to http://www.crestor.pgatour.com to take part in weekly contests, read about past Crestor Charity Challenge winners, and learn more about Crestor. Crestor also will be the official sponsor of Tour Fantasy Golf at pgatour.com/fantasy.

Source
AstraZeneca
Web Site: http://www.crestor.pgatour.com http://www.crestor.com